After several reports of blood clots developing in people who took the Johnson & Johnson CIVID-19 vaccine, U.S. health agencies called for a temporary
After several reports of blood clots developing in people who took the Johnson & Johnson CIVID-19 vaccine, U.S. health agencies called for a temporary halt on the shots. The J&J vaccine was pulled off the market last week after officials announced that six women — out of some 7 million people inoculated — had experienced blood clots. But what was expected to be a pause of just a few days is still in effect. Dr. Anthony Fauci, the top immunologist in the U.S., predicted on Sunday that health officials will not pull the vaccine. “My estimate is that we will continue to use it in some form. I doubt very seriously if they just cancel it,” the director of the National Institute of Allergy and Infectious Diseases said on NBC’s “Meet the Press.” “I do think that there will likely be some sort of warning or restriction or risk assessment. I don’t think it’s just going to go back and say, ‘OK, everything’s fine. Go right back,’” he said.
